Cidara Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CDTX)

CUSIP: 171757206

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
32,142,857
Total 13F shares
6,873,669
Share change
+3,565,221
Total reported value
$183,637,032
Price per share
$26.88
Number of holders
40
Value change
+$100,865,295
Number of buys
30
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 171757206?
CUSIP 171757206 identifies CDTX - Cidara Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cidara Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CDTX) as of Q4 2024

As of 31 Dec 2024, Cidara Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CDTX) was held by 40 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,873,669 shares. The largest 10 holders included BVF INC/IL, RA CAPITAL MANAGEMENT, L.P., TCG Crossover Management, LLC, VR Adviser, LLC, Bain Capital Life Sciences Investors, LLC, Vivo Capital, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, Checkpoint Capital L.P., and RENAISSANCE TECHNOLOGIES LLC. This page lists 40 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.